A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Dyskinesia in Cerebral Palsy in Children and Adolescents
Clinical trial NCT03813238 · COMPLETED
Trial details
- NCT number
- NCT03813238
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-06
- Primary completion
- 2022-07-05
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.